基础医学与临床 ›› 2020, Vol. 40 ›› Issue (2): 145-150.

• 研究论文 •    下一篇

CysLT2受体拮抗剂HAMI3379抑制LPS诱导小鼠小胶质瘤细胞系的炎性反应

顾胜龙1, 李明星1, 应苗法1, 方三华2, 饶跃峰3*, 赵蕊1*   

  1. 1.浙江大学医学院附属邵逸夫医院 药剂科, 浙江 杭州 310016;
    2.浙江大学医学院 公共技术平台,浙江 杭州 310058;
    3.浙江大学医学院附属第一医院 药剂科, 浙江 杭州 310003
  • 收稿日期:2019-03-22 修回日期:2019-07-04 出版日期:2020-02-05 发布日期:2020-02-05
  • 通讯作者: *3201039@zju.edu.cn;raoyf@zju.edu.cn
  • 基金资助:
    国家自然科学基金 (81872213); 浙江省自然科学基金(LYY19H310010); 浙江省公益技术应用研究计划 (2016C33131)

CysLT2 receptor antagonist HAMI3379 inhibits LPS-induced inflammation in mice microglia line BV-2

GU Sheng-long1, LI Ming-xing1, YING Miao-fa1, FANG San-hua2, RAO Yue-feng3*, ZHAO Rui1*   

  1. 1. Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016;
    2. Core Facilities, School of Medicine, Zhejiang University,Hangzhou 310058;
    3. Department of Pharmacy, the first Affiliated Hospital, Zhejiang University, Hangzhou 310003, China
  • Received:2019-03-22 Revised:2019-07-04 Online:2020-02-05 Published:2020-02-05
  • Contact: *3201039@zju.edu.cn;raoyf@zju.edu.cn

摘要: 目的 探究半胱氨酰白三烯2(CysLT2) 受体拮抗剂HAMI3379对LPS诱导小鼠小胶质细胞(BV-2)炎性反应的调控作用及其可能的作用机制。方法 体外培养BV-2,将BV-2分为对照组、LPS(100 ng/mL)组、HAMI3379(0.01、0.1和1 μmol/mL)组和LPS+ HAMI3379组。CCK-8法检测BV-2细胞的增殖;ELISA检测细胞上清液中炎性因子IL-1β、TNF-α、IL-10的含量;Western-blot检测PKCα、IKBα、NF-κB p50和p65蛋白的表达。结果 LPS能够激活BV-2细胞,促进其细胞的增殖(P<0.05);显著增加细胞上清液中炎性因子IL-1β、TNF-α的分泌,减少IL-10的分泌(P<0.05);且显著上调PKCα、IKBα、p65蛋白的表达水平(P<0.05)。CysLT2受体拮抗剂HAMI3379能够显著减轻上述变化(P<0.05)。结论 CysLT2受体拮抗剂HAMI3379能够抑制LPS激活BV-2细胞,抑制炎性反应,其作用机制可能与抑制PKCα/NF-κB信号通路有关。

关键词: CysLT2受体, HAMI3379, 炎性反应, PKCα/NF-κB信号通路

Abstract: Objective To investigate the role and possible mechanism of CysLT2 receptor antagonist HAMI3379 on the inflammatory response of mouse microglia (BV-2) induced by LPS. Methods BV-2 cells were divided into control group, LPS (100 ng/mL) group, HAMI3379 (0.01, 0.1 and 1 μmol/mL) group and LPS+HAMI3379 group. The proliferation of BV-2 cells was detected by CCK-8 assay. The contents of cytokines IL-1β, TNF-α and IL-10 were measured by ELISA assay. Western blot was used to detect the expression of PKCα,IKBα,NF-κB p50 and p65 protein. Results LPS significantly induced the activation of BV-2 cells and promoted proliferation of cells(P<0.05). The secretion of inflammatory factors IL-1β and TNF-α was significantly increased and the secretion of IL-10 was obviously reduced in cell supernatant(P<0.05). The expression of PKCα, IKBα and p65 proteins were significantly up-regulated(P<0.05). The CysLT2 receptor antagonist HAMI3379 was able to reduce these changes. Conclusions The CysLT2 receptor antagonist HAMI3379 may inhibit the activation of BV-2 cells induced by LPS and reduce the inflammatory response, and the possible mechanism is related to the inhibition of PKCα/NF-κB signaling pathway.

Key words: CysLT2 receptor, HAMI3379, inflammation, PKCα/NF-κB signaling pathway

中图分类号: